title: [Cancer in pregnancy].
abstract: Cancer in pregnancy occurs in about one in 1,000 pregnancies. Recent reports have shown that most treatment regimes in second and third trimester are safe for the mother and the child. This has led to a paradigm shift in treating pregnant women with cancer. The management of the pregnant woman should be in a multidisciplinary setting, and delivery should be postponed to avoid very preterm delivery and planned 2-3 weeks after the last chemotherapeutic treatment allowing both maternal and foetal bone marrow to recover.
authors.affiliation: Obstetrisk Klinik, Juliane Marie Centret, Rigshospitalet, Blegdamsvej 9, 2100 København Ø. berit.woetmann.pedersen@regionh.dk.
authors.forename: Berit Woetmann
authors.initials: BW
authors.lastname: Pedersen
authors.forename: Lone
authors.initials: L
authors.lastname: Storgaard
authors.forename: Mette Borg
authors.initials: MB
authors.lastname: Clausen
authors.forename: Niels
authors.initials: N
authors.lastname: Kroman
authors.forename: Jens
authors.initials: J
authors.lastname: Langhoff-Roos
authors.forename: Karina Dahl
authors.initials: KD
authors.lastname: Steffensen
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005298:Fertility; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000188:drug therapy; D011264:Pregnancy Trimesters
chemical_list: D000970:Antineoplastic Agents